About JAMA Ophthalmology
Neil M. Bressler, MD
JAMA Ophthalmology (formerly Archives of Ophthalmology), published continuously since 1869, is an international, peer-reviewed ophthalmology and visual science journal. JAMA Ophthalmology is a member of The JAMA Network family of journals, which includes JAMA and 11 specialty journals.
Journal Frequency and Access. JAMA Ophthalmology is published weekly online, every Thursday, and in 12 print/online issues per year. The journal receives approximately 1.3 million online visits annually, with 2.1 million article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the JAMA website. All articles are made free access on an html app called The JAMA Network Reader on the day of publication. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program.
Editorial Information. JAMA Ophthalmology's acceptance rate is 21% of the more than 1100 manuscripts submitted annually. The median time to first editorial decision is 5 days, and 40 days with peer review. Median time from submission to acceptance, including author revision, is 80 days, and from acceptance to publication is 58 days. All major articles are published online first. The journal's Impact Factor is 4.3, one of the highest in ophthalmology. For additional information on the types of articles published and editorial policies, see the journal's Instructions for Authors.
Editorial Team. The editor of JAMA Ophthalmology is Neil M. Bressler, MD. For a complete listing of the journal's Editors and Editorial Board, see link to Editors and Publishers below.
Mission Statement: To be the indispensable source of ophthalmic knowledge for the generalist, subspecialist, and trainee; to publish innovative, clinically relevant research for the vision scientist; to be the first choice for authors to submit their important manuscripts to; and to achieve this through authoritative peer review.
ISSN 2168-6165 (Print)
ISSN 2168-6173 (Online)
Back to top
Why Publish in JAMA Ophthalmology?
JAMA Ophthalmology (formerly Archives of Ophthalmology) publishes innovative, clinically relevant research.
Prompt Decisions and Rapid Publication Timelines
Every submission to JAMA Ophthalmology undergoes prompt, rigorous review by our experienced editors
- Highly selective peer review and editorial evaluation, with a 14% acceptance rate for research manuscripts
- Median time to first decision: 5 days; 40 days with peer review
- Online First: all major articles will be published quickly online first
- Rapid publication of clinical trials, including those from the Age-Related Eye Disease Study (AREDS), AREDS2, Comparison of AMD Treatment Trials (CATT), Diabetic Retinopathy Clinical Research Network, Early Treatment for Retinopathy of Prematurity Cooperative Group, MARINA and ANCHOR, Ocular Hypertension Treatment Study Group, Infant Aphakia Treatment Study Group, SCORE Study Group, Pediatric Eye Disease Investigators Group, RESTORE, RIDE and RISE investigators, Corneal Donor Study
Impact and Reach
- Impact Factor of 4.3, one of the highest in ophthalmology
- 33 million annual online visits to The JAMA Network
- 1.3 million annual visits to JAMA Ophthalmology website with 2.1 million article views and downloads
- Extensive press coverage, with more than 2,500 media mentions in 2015
- Broad reach through author audio and video interviews, email alerts, Twitter, Facebook, and Topic Collections
- International authors: 60% of submissions come from outside the United States; the acceptance rate for non-US submissions is 10%
- 125,000 registered users of The JAMA Network Reader, an app that integrates content across the entire JAMA Network of peer-reviewed journals and is accessible from any device without author fees as might be needed for "open access" journals
JAMA Ophthalmology offers unparalleled reach and an author-friendly approach, from manuscript submission through publication
- Prompt, expert review and consideration from our experienced editors
- Highest standards followed to improve your accepted manuscript's accuracy, reliability, and readability for both print and online publication
- CME credit available for lead authors who publish in JAMA Ophthalmology
- Opportunity for your work to be augmented with video and audio
- No author fees: no submission, page, color, or publication charges, unlike open access journals
- Free access: All research articles are freely available on the day of publication on The JAMA Network Reader and 12 months after publication on the journal's website.
- Online extras: ability to post supplemental content online and download your article's tables and figures as PowerPoint slides
- The JAMA Network advantage: Authors of papers not accepted by JAMA may have their papers automatically referred to JAMA Ophthalmology
For more information, see JAMA Ophthalmology Instructions for Authors. Submit your manuscript at http://manuscripts.jamaophth.com.
Back to top
Updated October 2016